2006
DOI: 10.1016/j.pharmthera.2005.12.003
|View full text |Cite
|
Sign up to set email alerts
|

Elastic fibres and vascular structure in hypertension

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

10
191
0
7

Year Published

2009
2009
2022
2022

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 218 publications
(208 citation statements)
references
References 225 publications
10
191
0
7
Order By: Relevance
“…Age-related reductions in arterial compliance (known as arteriosclerosis) lead to increases in systolic blood pressure in the aorta, a major risk factor for the development of heart failure (Mitchell 2008;O'Rourke and Hashimoto 2007). It is still unclear, however, whether vascular hypertension is a cause, or symptom, of this arterial stiffening (Arribas et al 2006;McEniery et al 2007). In addition to heart failure, chronic hypertension is implicated as a major risk factor in the development of strokes (Nilsson 2005), renal failure (Lariviere and Lebel 2003) and aortic aneurysms (Lederle et al 2008).…”
Section: Vascularmentioning
confidence: 99%
“…Age-related reductions in arterial compliance (known as arteriosclerosis) lead to increases in systolic blood pressure in the aorta, a major risk factor for the development of heart failure (Mitchell 2008;O'Rourke and Hashimoto 2007). It is still unclear, however, whether vascular hypertension is a cause, or symptom, of this arterial stiffening (Arribas et al 2006;McEniery et al 2007). In addition to heart failure, chronic hypertension is implicated as a major risk factor in the development of strokes (Nilsson 2005), renal failure (Lariviere and Lebel 2003) and aortic aneurysms (Lederle et al 2008).…”
Section: Vascularmentioning
confidence: 99%
“…These alterations include increases in the degradation and synthesis of collagen and the destruction and reconstruction of elastin fibers, which eventually lead to remodeling of the arterial wall and modifications of its mechanical properties.The mechanism by which hypertension accelerates atherogenesis remains unclear. Tensile stretch on vascular cells may influence cell behavior, such as proliferation, apoptosis, and alterations in gene expression of the ECM [17,29]. However, it is well established that the development of hypertension is associated with an increase in ECM proteins, including elastin, in the arterial wall.…”
Section: Discussionmentioning
confidence: 99%
“…Clinical data and characteristics of the study groups are given in table. This definition was given by the National High Pressure Education Program [17].…”
Section: Tissue Samplesmentioning
confidence: 99%
“…The turnover rate for collagen and elastin is low in healthy arteries, but vascular pathology upsets the regulatory pathways that maintain this balance. In response to hypertension, the overexpression of both proinflammatory and proteinase-inhibitory molecules dramatically increases arterial ECM synthesis (Arribas et al, 2006;Jacob et al, 2001;Jacob, 2003). Elastin and elastic fibers are progressively degraded by enzymatic processes involving an age-related imbalance between anti-proteases and proteases.…”
Section: Introductionmentioning
confidence: 99%
“…Imbalance in matrix metalloproteinase/tissue inhibitors of metalloproteinases may contribute to alteration in collagen turnover and extracellular matrix remodelling. However, the ECM proteins synthesized in response to hypertension have a threedimensional architecture that is functionally less optimal than those deposited during fetal development and may play an important role in determining the modulus of pathological elastin tissue (Arribas et al, 2006;Jacob et al, 2001;Jacob, 2003). The increase of aortic stiffness is not only because of enzymatic degradation of elastin, but also is due to other mechanisms mainly including age-dependent increase in the collagen content and arterial wall thickening, non-enzymatic glycation of proteins (elastin and collagens), leading to the formation of deleterious advanced glycation end-products (AGEs) and related molecular cross-links which modify the tissue mechanical properties (Gibbons & Dzau, 1994;Corman et al, 1998;Lakatta, 2003;O'Routke, 2007).…”
Section: Introductionmentioning
confidence: 99%